|
|
 |
|
Viewing report
|
|
|
|
Pharma Industry Panel in Brazil (Portuguese Version)
Praxian, June 2010, Pages: 56
With the launch of the First Edition of the Panel on Drug Industry-FIP, we offer our contribution to the development of this industry in Brazil. In an industry in which quantitative information about the sale and consumption of drugs are widely available, the purpose of FIP is to provide a tool for dialogue on strategic issues, forming a clear picture of market trends in view of the industry itself, which by first evaluates itself in a systematic way. In the following pages, readers may have contact with the key information and analysis resulting from the survey, whose results may be very helpful in business strategies for the year 2010 onwards. In this edition, the themes were the moti-vating factors and trends of Mergers and Acquisitions, Investment Management and Pipeline Products, Communication Management and Distribution. Every-thing from the perspective of professionals who are at the forefront of decision making in the industry. Great reading and great business!
The FIP edition of March-June 2010 brings out the challenges that await the industry in the present and future years. The clear trend is an increase in com-petitiveness of businesses in several fronts: the acquisition of other companies, developing new market strategies, product launches for innovative ways, new forms of partnerships between business, conflicts of distribution channels and major changes in form of communication with the medical profession. The first discusses the point of views of the leaders of this dynamic and chal-lenging industry. It will be a valuable source of information so you and your company can come out strengthened the moments of turbulence ahead.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
This title is also available in the following language
Pharma Industry Panel in Brazil (English Version)
Customers who bought this item also bought
Pharma Industry Panel in Brazil
Healthcare, Regulatory and Reimbursement Landscape - Brazil
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market
Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs
Orphan Drug Markets in Europe: Key Developments and the Strategies of Major Pharmaceutical Companies
Brazil Pharmaceutical Market Overview - Expanding healthcare access drives double-digit sales growth
Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment
Global Prostate Cancer Therapeutics Market (2010 – 2020) (Opportunity Analysis, Pipeline Assessment & Market Forecast)
First Aid Kits in the BRIC (Brazil, Russia, India, China) Countries - Market Overview and Forecasts to 2014
Market Access Brazil: Unlocking Pharma Potential.
|
|
|
|
